Skip to Content
Opening Bell
News
BenzingaOctober 23, 2026 at 2:30 AM NY4 Days Ago

HC Wainwright & Co. Downgrades Avalo Therapeutics to Neutral

HC Wainwright & Co. analyst Mitchell S. Kapoor downgrades Avalo Therapeutics (NASDAQ:AVTX) from Buy to Neutral.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga

Read at Source